A first result of that partnership is a three year deal with the Clinical Research Department of the Singapore General Hospital (SGH). SGH will apply the Genomatix Chip Analysis pipeline to their Affymetrix based expression studies.
"I am very excited about this partnership with RI," says Klaus May, Director of Sales & Marketing at Genomatix.
He continues, "Beyond other technologies, RI is one of the strongest providers of Affymetrix chips and services in this area. With our ChipInspector and GenomatixSuitePE products, now RI is a one-stop-shop for providing latest science, technology and services in South East Asia."